Płaza, O.; Gałecki, P.; Orzechowska, A.; Gałecka, M.; Sobolewska-Nowak, J.; Szulc, A.
Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics? Biomedicines 2022, 10, 3165.
https://doi.org/10.3390/biomedicines10123165
AMA Style
Płaza O, Gałecki P, Orzechowska A, Gałecka M, Sobolewska-Nowak J, Szulc A.
Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics? Biomedicines. 2022; 10(12):3165.
https://doi.org/10.3390/biomedicines10123165
Chicago/Turabian Style
Płaza, Olga, Piotr Gałecki, Agata Orzechowska, Małgorzata Gałecka, Justyna Sobolewska-Nowak, and Agata Szulc.
2022. "Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?" Biomedicines 10, no. 12: 3165.
https://doi.org/10.3390/biomedicines10123165
APA Style
Płaza, O., Gałecki, P., Orzechowska, A., Gałecka, M., Sobolewska-Nowak, J., & Szulc, A.
(2022). Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics? Biomedicines, 10(12), 3165.
https://doi.org/10.3390/biomedicines10123165